Clinical Trial Update: Nab-PCE vs PC for MM After Failure of Anti-PD-1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing nab-Paclitaxel + carboplatin versus paclitaxel + carboplatin in advanced melanoma after anti-PD-1 failure is ongoing with unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PC
• nab-PCE (nanoparticle albumin-bound paclitaxel + carboplatin)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Advanced Melanoma | Phase 2 | Status: UNKNOWN